New Product Launches Benefit GMED Stock Amid Macro Issues

Globus Medical (GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. However, the challenging macroeconomic scenario continues to plague Globus Medical. The stock currently carries a Zacks Rank #3 (Hold).Factors Driving GMED's SharesGlobus Medical is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments used in an expansive range of spinal, orthopedic ...